BridgeBio Pharma Stock (NASDAQ: BBIO) stock price, news, charts, stock research, profile.
You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.
Other companies in BridgeBio Pharma’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
BridgeBio Pharma has a consensus price target of $43.72.
The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $27.3 last updated November 25, 2024 at 4:37 PM EST.
There are no upcoming dividends for BridgeBio Pharma.
BridgeBio Pharma’s Q4 earnings are confirmed for Thursday, February 20, 2025.
There is no upcoming split for BridgeBio Pharma.
BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.